Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Liberg

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Frontiers in Immunology|January 10, 2022
Molecular Basis of Selective Cytokine Signaling Inhibition by Antibodies Targeting a Shared ReceptorJames K Fields, Kyle Kihn, Gabriel S Birkedal, et al.
British Journal of Cancer|December 14, 2021
First-in-human phase 1 dose-escalation study of CAN04, a first-in-class interleukin-1 receptor accessory protein (IL1RAP) antibody in patients with solid tumoursDebbie Robbrecht, Christiane Jungels, Morten Mau Sorensen, et al.
Circulation. Heart Failure|November 8, 2024
IL1RAP Blockade With a Monoclonal Antibody Reduces Cardiac Inflammation and Preserves Heart Function in Viral and Autoimmune MyocarditisDiego A Lema, Gabriel Jakobsson, Abdel Daoud, et al.
Immunity|March 17, 2007
Ikaros DNA-binding proteins as integral components of B cell developmental-stage-specific regulatory circuitsElizabeth C Thompson, Bradley S Cobb, Pierangela Sabbattini, et al.
Journal for Immunotherapy of Cancer|December 18, 2024
Blocking IL1RAP on cancer-associated fibroblasts in pancreatic ductal adenocarcinoma suppresses IL-1-induced neutrophil recruitmentNils Hansen, Pablo Peña-Martínez, Petter Skoog, et al.
JCI Insight|June 22, 2026
IL1RAP-expressing myeloid-stromal networks represent a therapeutic vulnerability to improve chemoimmunotherapy sensitivity in pancreatic cancerErin M Dickey, Harper M Marsh, Camilla Rydberg-Millrud, et al.
Cardiovascular Research|April 2, 2024
Interleukin-1 receptor accessory protein blockade limits the development of atherosclerosis and reduces plaque inflammationMegan Mulholland, Marie A C Depuydt, Gabriel Jakobsson, et al.
Annals of the Rheumatic Diseases|April 9, 2024
Combined inhibition of IL-1, IL-33 and IL-36 signalling by targeting IL1RAP ameliorates skin and lung fibrosis in preclinical models of systemic sclerosisCaitríona Grönberg, Sara Rattik, Cuong Tran-Manh, et al.
Cell Reports|April 18, 2024
Antibodies targeting the shared cytokine receptor IL-1 receptor accessory protein invoke distinct mechanisms to block all cytokine signalingJames K Fields, Elin Jaensson Gyllenbäck, Marek Bogacz, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Frontiers in Immunology|January 10, 2022
Molecular Basis of Selective Cytokine Signaling Inhibition by Antibodies Targeting a Shared ReceptorJames K Fields, Kyle Kihn, Gabriel S Birkedal, et al.
British Journal of Cancer|December 14, 2021
First-in-human phase 1 dose-escalation study of CAN04, a first-in-class interleukin-1 receptor accessory protein (IL1RAP) antibody in patients with solid tumoursDebbie Robbrecht, Christiane Jungels, Morten Mau Sorensen, et al.
Circulation. Heart Failure|November 8, 2024
IL1RAP Blockade With a Monoclonal Antibody Reduces Cardiac Inflammation and Preserves Heart Function in Viral and Autoimmune MyocarditisDiego A Lema, Gabriel Jakobsson, Abdel Daoud, et al.
Immunity|March 17, 2007
Ikaros DNA-binding proteins as integral components of B cell developmental-stage-specific regulatory circuitsElizabeth C Thompson, Bradley S Cobb, Pierangela Sabbattini, et al.
Journal for Immunotherapy of Cancer|December 18, 2024
Blocking IL1RAP on cancer-associated fibroblasts in pancreatic ductal adenocarcinoma suppresses IL-1-induced neutrophil recruitmentNils Hansen, Pablo Peña-Martínez, Petter Skoog, et al.
JCI Insight|June 22, 2026
IL1RAP-expressing myeloid-stromal networks represent a therapeutic vulnerability to improve chemoimmunotherapy sensitivity in pancreatic cancerErin M Dickey, Harper M Marsh, Camilla Rydberg-Millrud, et al.
Cardiovascular Research|April 2, 2024
Interleukin-1 receptor accessory protein blockade limits the development of atherosclerosis and reduces plaque inflammationMegan Mulholland, Marie A C Depuydt, Gabriel Jakobsson, et al.
Annals of the Rheumatic Diseases|April 9, 2024
Combined inhibition of IL-1, IL-33 and IL-36 signalling by targeting IL1RAP ameliorates skin and lung fibrosis in preclinical models of systemic sclerosisCaitríona Grönberg, Sara Rattik, Cuong Tran-Manh, et al.
Cell Reports|April 18, 2024
Antibodies targeting the shared cytokine receptor IL-1 receptor accessory protein invoke distinct mechanisms to block all cytokine signalingJames K Fields, Elin Jaensson Gyllenbäck, Marek Bogacz, et al.
Pageof 3